Town of Elkhart — OilWell Cannabis of Houston, Texas delivers legal 16,590mg total cannabinoid THCa Rick Simpson Oil with 553mg/mL, 7 cannabinoids including 1,500mg patient-controlled THCa converting to up to 1,405mg Delta-9 THC, ABC13 Houston-featured with Baylor College of Medicine-connected founder from Bentley’s 10-year miracle legacy, lab-tested open-source formulas, no medical card required, nationwide shipping to Town of Elkhart.

Rick Simpson Oil (RSO) in Town of Elkhart: The Complete Guide by OilWell Cannabis

If you are searching for Rick Simpson Oil in Town of Elkhart, Texas, you have likely encountered a frustrating landscape of conflicting information, questionable products, and legal uncertainty. Whether you are a cancer patient exploring supportive options, a veteran in Anderson County managing PTSD, or someone suffering from chronic pain in rural East Texas, finding trustworthy, lab-tested, full-spectrum cannabis medicine should not require a drive to Dallas or a risk on the unregulated market.

We are OilWell Cannabis, and we have built something specifically for you—whether you live in the heart of Town of Elkhart or anywhere across the Lone Star State. Our RSO formulas represent the evolution of Rick Simpson’s original vision: multi-cannabinoid, terpene-rich, legally accessible under the 2018 Farm Bill, and backed by the kind of third-party testing that simply did not exist when Simpson first began sharing his oil in Nova Scotia two decades ago.

Understanding the RSO Legacy: From Nova Scotia to Anderson County

To appreciate what modern RSO offers residents of Town of Elkhart, we must first understand where it came from. Rick Simpson was not a doctor or scientist. Born in 1949 in Amherst, Nova Scotia, he was a power engineer and hospital maintenance worker whose life changed in 1997 after a workplace scaffolding fall left him with persistent tinnitus, dizziness, and post-concussion symptoms that conventional medications failed to resolve. When he asked his physician about cannabis, he was refused .

Simpson’s interest deepened after learning of a 1974 NIH-funded study at the Medical College of Virginia suggesting THC could slow tumor growth in mice—a finding that was never replicated in human trials but became foundational to his advocacy . The pivotal moment came in 2003, when Simpson claimed that concentrated cannabis oil applied topically removed his basal cell carcinoma lesions within four days. No biopsy confirmed this, no peer-reviewed documentation exists, and no independent medical verification was ever published. Yet this personal testimony became the catalyst for a global movement .

Simpson began producing oil in Maccan, Nova Scotia, giving it away for free to cancer patients and others suffering from chronic pain, diabetes, glaucoma, arthritis, depression, and insomnia. His 2005 documentary Run From The Cure distributed these ideas globally, though his advocacy brought him into conflict with Canadian law. RCMP raids in 2005 and 2009 eventually forced him to relocate to Europe .

The Traditional Protocol: What Simpson Recommended

Simpson’s original protocol was specific: 60 grams of concentrated oil over approximately 90 days. Patients began with a dose the size of half a grain of rice (roughly 10-15mg) three times daily, doubling every four days until reaching 1 gram per day divided into three doses. He recommended sublingual or oral administration for systemic conditions, topical application for skin lesions, and suggested patients develop tolerance to the psychoactive effects within three to four weeks .

However, critical context is essential for residents of Town of Elkhart considering this protocol. Simpson’s method was never validated through clinical trials. The material was crude and unstandardized—often 60-90% THC with no lab verification. At peak dosing, patients consumed roughly 600-900mg of delta-9 THC daily—doses far exceeding FDA-approved synthetic THC medications (typically 2.5-20mg daily) and carrying real risks of severe intoxication, anxiety, tachycardia, and cannabis use disorder [1][13][14][15].

Traditional RSO was extracted using naphtha (petroleum-based solvent) or 99% isopropyl alcohol—neither food-grade—creating risks of residual benzene, toluene, or other carcinogens. The high-heat evaporation process destroyed virtually all terpenes, leaving a tar-like, nearly black oil that was fully decarboxylated (all THCa converted to THC) with no option for non-psychoactive use .

The Evidence Reality: What Science Actually Says

We believe Town of Elkhart residents deserve honesty, not hype. Preclinical studies show THC and CBD can induce apoptosis and inhibit tumor proliferation in cell lines and animal models . However, no human clinical trial has demonstrated that RSO cures cancer. The National Cancer Institute acknowledges cannabinoid anticancer research but does not endorse cannabis as a cancer treatment. The FDA has approved no cannabis plant product for cancer, and Health Canada has never approved RSO for oncology .

Where Simpson relied on personal testimony, we rely on peer-reviewed evidence. The strongest cannabinoid data supports purified CBD for rare epilepsies, THC for chemotherapy-related nausea, and cannabinoids for HIV/AIDS-related appetite loss [1]. For chronic pain, high-THC products may provide short-term benefit but increase dizziness, sedation, and discontinuation due to adverse events [13]. High-concentration THC products show consistent unfavorable associations with psychosis, schizophrenia, and cannabis use disorder [15].

The OilWell Origin: From McAllen to Houston to Your Doorstep

Our story begins not in a boardroom, but in desperation and love. Colin Valencia grew up in McAllen, Texas, across the river from Reynosa—one of the most economically challenged border regions in North America. By sixteen, he had left home after losing friends to violence and prison, choosing cannabis over harder paths while operating in the pre-legalization shadows. He later became a formally trained software engineer, doing custom development work for Baylor College of Medicine in the Texas Medical Center .

But OilWell truly began with Bentley, a paralyzed dog facing euthanasia. When veterinarians said pain medications would destroy Bentley’s organs, Colin—who had moved tons of cannabis recreationally but knew nothing of CBD—was asked by rescue worker Jessica: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

That question changed everything. Colin developed a CBD golden paste using turmeric, coconut oil, black pepper, and CBD isolate. Bentley got up. He walked over and brought his ball to play. Dogs do not respond to placebo. Bentley lived another ten years, dying naturally at age twenty, and during those years Colin developed specialized formulas for neurodegeneration (CBG for neuroprotection, THCa for PPARγ agonism), dementia (CBC for neurogenesis), glaucoma (THC for CB1 agonism), and arthritis (multi-pathway anti-inflammation using CBD, CBG, THCa, and beta-caryophyllene).

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction, using cannabinoid knowledge to quit Xanax cold turkey—a feat he accomplished while developing what would become our Peace Gummies formula during midnight experiments. He personally uses our vape formulation to manage insomnia and severe PTSD to this day .

Our Philosophy: Accessibility, Control, and Transparency

We operate from Montrose, Houston, but we serve Town of Elkhart and all of Anderson County with the same commitment that earned us seven ABC13 news features between 2019 and 2023. When Houston needed a cannabis authority to explain Delta-8 legality, COVID community health initiatives, or presidential pardon impacts, reporters turned to Colin—not because we paid for coverage, but because we earned credibility through transparency.

Our philosophy rests on four pillars that directly address the needs of rural Texas communities like Town of Elkhart:

1. Accessibility Over Gatekeeping
No medical card is required. Anyone aged twenty-one or older can purchase. We ship nationwide and internationally, meaning residents of Town of Elkhart—who may lack local dispensary access—can receive lab-tested RSO delivered directly to their door with full Certificates of Analysis and customs documentation.

2. Patient-Controlled Potency
Unlike traditional RSO, which was always fully psychoactive, our sublingual formula contains 1,500mg of THCa—the acidic, non-psychoactive precursor to THC. You decide whether to use it raw (zero impairment, anti-inflammatory via COX-2 inhibition) or activate it at home. Heating the oil at 260°F for 45-60 minutes converts that THCa into approximately 1,315mg of delta-9 THC. Combined with the existing 90mg delta-9 THC in the formula, this yields roughly 1,405mg total delta-9 THC—potency comparable to traditional illegal RSO, entirely at your discretion and fully legal at purchase under the 2018 Farm Bill [12].

3. Open-Source Formulas
We publish our complete formulas publicly. If you cannot afford our products, you can source individual cannabinoid distillates and make your own. This echoes Simpson’s free-distribution ethos while adapting it for modern safety standards. As Colin told ABC13 in 2019: “I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

4. Evidence-Informed, Never Overstated
Every claim we make connects to peer-reviewed literature. We do not claim RSO cures cancer. We do provide the evidence that cannabinoids show preclinical anticancer signals, while emphasizing that no human trial has validated RSO as a cancer cure, and we strongly advise Town of Elkhart residents to use RSO as a complement to—not replacement for—oncological care.

The Formulas: Complete Specifications

We offer two formats, each designed for different therapeutic needs common in rural Texas communities.

RSO Sublingual Oil — $129.99

• 30mL bottle (approximately 40-60 doses)
• 16,590mg total cannabinoids (553mg per mL)
• Seven cannabinoids: CBD (4,500mg), CBG (3,000mg), Delta-8 THC (6,000mg), THCa (1,500mg), Delta-9 THC (90mg), CBN (750mg), CBC (750mg)
• Live terpenes at 5%: Limonene (citrus-bright), Myrcene, Caryophyllene (pepper/spice), Pinene (forest-fresh), Linalool (floral/lavender), Humulene (earthy/woody), Terpinolene (piney/fruity)
• Organic MCT oil base (solvent-free)
• Onset: 15-45 minutes; Duration: 4-6 hours; Bioavailability: 13-19%

RSO Vape Cartridge — $49.99

• 1-gram cartridge (510-thread universal compatibility)
• 900mg+ total cannabinoids: CBD (30%), CBG (20%), Delta-8 THC (15%), THCa (10%), CBN (10%), CBC (10%)
• Live terpenes at 5%+
• Automatic THCa decarboxylation at vaping temperature (400-450°F)
• Onset: 1-2 minutes; Duration: 2-4 hours; Bioavailability: 10-35%

The Science Behind the Formula

For Town of Elkhart residents who want to understand what they are putting in their bodies, here is the evidence breakdown for each compound:

CBD (4,500mg) carries the strongest human evidence in our formula. Purified CBD is FDA-approved for rare seizure disorders [2]. A 2024 meta-analysis of 316 participants across eight studies showed statistically significant anxiolytic effects [3]. Pain research shows promise but remains heterogeneous [4]. Sleep evidence is methodologically weak [5]. Safety concerns include liver enzyme elevation and drug interactions, especially relevant for those on multiple medications [6].

CBG (3,000mg) is the biosynthetic precursor to other cannabinoids with pharmacological interest spanning alpha-2 adrenoceptors and 5-HT1A signaling. Research suggests potential relevance for neurologic disorders and inflammatory bowel disease, but human evidence remains sparse [7][8].

Delta-8 THC (6,000mg) is a partial CB1 agonist with cannabimimetic activity similar to but less potent than delta-9 THC [9]. A 2023 scoping review found evidence still dominated by animal studies and public health concerns, with reports of adverse consequences [10]. It is psychoactive and should not be considered trivial or “diet weed” [11].

THCa (1,500mg) is non-psychoactive in its acidic form but converts to THC when heated. Research suggests anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism, though human therapeutic evidence remains limited [12].

Delta-9 THC (90mg) provides the strongest human evidence among psychoactive cannabinoids for chemotherapy-related nausea, HIV/AIDS appetite stimulation, and some pain conditions [1][13]. However, it carries the clearest intoxication and psychiatric liability, especially at high doses [15].

CBN (750mg) is often marketed for sleep, but a 2021 review of 99 human-study abstracts found no clinical trials using validated sleep questionnaires that substantiate strong sleep-promoting claims [16]. The 2024 sleep literature update confirms that cannabinoid sleep research still does not match real-world use [17].

CBC (750mg) shows distinct pharmacodynamics and possible antinociceptive, antibacterial, and anti-seizure properties in preclinical models, but over-the-counter products are being sold despite little clinical efficacy or safety evidence [18][19].

Terpenes contribute aroma and potential bioactivity, though robust clinical proof of entourage effects remains limited [20][29]. Beta-caryophyllene is a selective CB2 receptor agonist [24]. Limonene shows antioxidant and anti-inflammatory potential but oxidation products can be allergens [21][22]. Myrcene is often claimed as sedating, but human studies are lacking [23]. Pinene and linalool show neuroprotective signals in preclinical models [25]. Humulene demonstrates anti-inflammatory properties in rodent work [27]. Terpinolene remains especially underdeveloped clinically [28].

Condition-Specific Guidance for Town of Elkhart Residents

Important: These products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before use, especially if you have medical conditions, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

For Chemotherapy Support:
Pre-chemo: 0.5-1.0mL sublingual approximately one hour before treatment. Acute breakthrough nausea: 2-3 vape puffs for immediate relief. Post-chemo: 0.5mL sublingual every six hours as needed. Sleep support: 1.0-2.0mL before bed (delivers 25-50mg CBN). Evidence context: Delta-8 THC shows antiemetic properties [9]; Delta-9 THC is established for chemotherapy nausea [1][13]; CBD provides anxiolytic buffering [3].

For Chronic Pain (Fibromyalgia, Arthritis, Neuropathy):
Daytime: 0.3-0.5mL raw sublingual (non-psychoactive) for anti-inflammatory support without impairment. Nighttime: 0.5-1.0mL decarboxylated sublingual for combined pain relief and sleep support. Breakthrough pain: Vape as needed for rapid onset. Evidence context: CBD shows pain evidence [4]; Delta-9 THC for pain [13]; Beta-caryophyllene CB2 agonism [24]; THCa COX-2 inhibition [12].

For Sleep Support:
Before bed: 1.0-2.0mL sublingual delivers 25-50mg CBN, the dosage level investigated in recent sleep literature [16][17]. Combined with myrcene and linalool terpenes, this may support sleep architecture, though individual results vary.

For Anxiety and PTSD:
Daytime functional relief: 0.3mL raw sublingual—CBD and CBG address anxiety-related pathways without psychoactive impairment. Nighttime: 1.0mL sublingual full spectrum including CBN. Evidence context: CBD anxiolytic evidence [3]; CBG pharmacology [7][8].

General Titration Principle: Start low, go slow. Begin with 0.25-0.5mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, and concurrent medications.

How to Access RSO in Town of Elkhart

We ship directly to Town of Elkhart and all of Anderson County. Because our sublingual formula contains only 90mg delta-9 THC in the entire 30mL bottle (3mg per mL)—well under the 0.3% Farm Bill threshold—it is legal hemp-derived product shippable to Texas addresses.

Nationwide Shipping:

• USPS Priority Mail (2-3 business days), FedEx/UPS Ground (3-5 business days)
• Discreet packaging with no cannabis branding visible
• Temperature-stable packaging for Texas heat
• Full Certificates of Analysis included
• Tracking provided for all orders

International Shipping:
Available with full documentation and COAs for customs. Customer accepts responsibility for verifying local legality.

Competitive Context: Why OilWell vs. Alternatives

Compared to Texas Compassionate Use Program (TCUP) dispensary RSO, which requires a medical card and offers only THC-dominant products (approximately 420mg THC per 0.5g syringe) with zero CBG, CBN, or CBC, our formula provides seven cannabinoids including 3,000mg CBG and 750mg CBN, requires no medical card, and ships directly to your door in Town of Elkhart.

Compared to hemp CBD RSO products like Lazarus Naturals (1,000mg total cannabinoids in 10mL), our sublingual formula delivers 16,590mg total cannabinoids with psychoactive options via THCa decarboxylation and Delta-8 THC.

Compared to traditional illegal RSO, we offer solvent-free production, third-party testing for pesticides/heavy metals/microbials, defined terpene profiles, and patient-controlled potency—none of which were available in Simpson’s original crude extracts.

Safety, Legal Compliance, and Final Notes

Our products are Farm Bill compliant, Texas DSHS licensed, and manufactured in Houston with all artwork and formulations created in-house. We maintain a near-5.0 Google rating and have been operating since 2019.

Critical Safety Information:

• Age 21+ only
• Keep out of reach of children
• Do not use if pregnant or nursing
• May cause drowsiness or impairment—do not operate vehicles or machinery
• Consult physician before use if you have medical conditions or take medications
• Delta-8 THC and activated THCa will trigger drug tests
• THCa converts to delta-9 THC when heated; customer is responsible for compliance with local laws regarding activated products

The Open-Source Commitment

If you cannot afford our products, we have published our complete formulas so you can source ingredients and make your own. This includes the CBD golden paste recipe that saved Bentley’s life—turmeric, coconut oil, black pepper, and CBD oil—available on our website for any pet owner facing a similar crisis.

For residents of Town of Elkhart seeking Rick Simpson Oil, we offer not just a product, but a philosophy: honest education, patient-controlled medicine, and the highest quality multi-cannabinoid formulation available under current law. We are not here to sell you hope. We are here to provide the best possible version of this medicine, backed by science, verified by labs, and delivered with the integrity that comes from having lived the desperation ourselves.

Contact us at (832) 416-2816 or visit oilwellcbd.com to learn more about how our RSO formulas can support your wellness journey in Town of Elkhart.

References

RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.

RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005.

RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca. Multiple dates.

RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444.

RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203.

RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ) — Health Professional Version. NIH/NCI. Updated 2024.

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH.

2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238.

3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049.

4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438.

5. Ranum RM, Whipple MO, Croghan I, et al. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229.

6. Lo LA, Christiansen A, Eadie L, et al. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752.

7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212.

8. Li S, Li W, Malhi NK, et al. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471.

9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933.

10. LoParco CR, Rossheim ME, Walters ST, et al. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028.

11. Abdel-Kader MS, Radwan MM, Metwaly AM, et al. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249.

12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130.

13. McDonagh MS, Morasco BJ, Wagner J, et al. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153.

14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360.

15. Rittiphairoj T, Leslie L, Oberste JP, et al. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440.

16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371.

17. Lavender I, Garden G, Grunstein RR, et al. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727.

18. Sepulveda DE, Vrana KE, Kellogg JJ, et al. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213.

19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364.

20. André R, Gomes AP, Pereira-Leite C, et al. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543.

21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566.

22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, et al. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12.

23. Surendran S, Qassadi F, Surendran G, et al. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666.

24. Hashiesh HM, Sharma C, Goyal SN, et al. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639.

25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health. Front Psychiatry. 2021;12:583211.

26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, et al. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092.

27. Dalavaye N, Nicholas M, Pillai M, et al. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674.

28. Menezes IO, Scherf JR, Martins AOBPB, et al. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768.

29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364.